ST 분절 상승 심근경색증 환자에서 좌심실 질량 변화의 임상적 의의

DC Field Value Language
dc.contributor.advisor탁승제-
dc.contributor.author박진선-
dc.date.accessioned2019-10-21T07:32:08Z-
dc.date.available2019-10-21T07:32:08Z-
dc.date.issued2018-02-
dc.identifier.other26769-
dc.identifier.urihttps://dspace.ajou.ac.kr/handle/2018.oak/19260-
dc.description학위논문(박사)--아주대학교 일반대학원 :의학과,2018. 2-
dc.description.tableofcontentsⅠ. Introduction 1 Ⅱ. Material and Method 2 A. Subject Population 2 B. Definition of Left Ventricular Mass and its Progression 2 C. Study End-points 3 D. Statistical analysis 3 Ⅲ. Results 4 Ⅳ. Discussion 17 Ⅴ. Conclusion 20 References 21 국문요약 24-
dc.language.isoeng-
dc.publisherThe Graduate School, Ajou University-
dc.rights아주대학교 논문은 저작권에 의해 보호받습니다.-
dc.titleST 분절 상승 심근경색증 환자에서 좌심실 질량 변화의 임상적 의의-
dc.title.alternativePrognostic Impact of Left Ventricular Mass Change in Patients with ST-elevation Myocardial Infarction-
dc.typeThesis-
dc.contributor.affiliation아주대학교 일반대학원-
dc.contributor.alternativeNameJin-Sun Park-
dc.contributor.department일반대학원 의학과-
dc.date.awarded2018. 2-
dc.description.degreeDoctoral-
dc.identifier.localId800841-
dc.identifier.urlhttp://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000026769-
dc.subject.keywordLeft Ventricular Hypertrophy-
dc.subject.keywordMyocardial Infarction-
dc.subject.keywordPrognosis-
dc.description.alternativeAbstractBackground: Prognostic significance between progression of left ventricular hypertrophy (LVH) and clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) is uncertain. The objective of this study was to investigate prognostic impact of progression of LV mass index (LVMI) in patients with STEMI. Methods: We analyzed the data and clinical outcomes of patients with STEMI who received successful coronary intervention. A total of 200 patients who had echocardiographic follow-up between 12 and 36 months were finally enrolled. According to change in LVMI compared to baseline LVMI, patients were classified into progression group and non-progression group. Progression of LVMI was defined when increment of LMVI was greater than 10% compared to baseline LVMI. End points were major adverse cardiac events within 5 years, including death, recurrent MI, target vessel revascularization, and hospitalization due to heart failure. Results: Progression of LVMI occurred in 55 patients. In the progression group, rate of recurrent MI was higher (13 vs. 2 %, P = 0.026) and the event-free survival of recurrent MI was significantly worse (log-rank P < 0.001) than that in the non-progression group. Adjusted hazard ratio of progression of LVMI for recurrent MI was 10.253 (95% confidence intervals 2.019-52.061, P = 0.005). Conclusion: Increased LVMI was an independent predictor for adverse events, especially for recurrent MI, in patients with STEMI.-
Appears in Collections:
Graduate School of Ajou University > Department of Medicine > 4. Theses(Ph.D)
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse